Adults aged 20 and older should have their cholesterol measured.
The guidelines of the National Cholesterol Education Program recommend that adults =20 years of age should have their total and high-density lipoprotein cholesterol measured.
This recommendation, which has been endorsed by representatives of>40 medical and health organizations, is based on a large and diverse body of scientific evidence derived from animal, pathologic, genetic, biochemical, metabolic, and epidemiologic studies and clinical trials.
Elevated cholesterol levels raise the risk of coronary heart disease (CHD) in men and women and in younger and older adults.
Recent clinical trials have confirmed that cholesterol lowering reduces CHD morbidity and mortality and total mortality, without an increase in noncardiovascular mortality, in patients with and without CHD.
Measuring cholesterol levels in adults =20 years of age is necessary to provide an accurate assessment of CHD risk to an individual ; to identify individuals who should lower their cholesterol levels, using diet and lifestyle changes as the primary treatment ; and to reinforce population recommendations.
Atherosclerosis begins early in life, and cholesterol levels in young adults predict CHD risk 30-40 years later.
Cholesterol measurement can be used to motivate lifestyle changes that will reduce the long-term risk for CHD.
Waiting until mid-life to find an elevated cholesterol loses a significant portion of the benefit. (...)
Mots-clés Pascal : Cholestérol, Dosage, Critère âge, Recommandation, Programmation objectif, Facteur prédictif, Cardiopathie coronaire, Surveillance, Complication, Homme, Adulte jeune, Métabolisme pathologie, Dyslipémie, Hyperlipoprotéinémie, Education santé, Economie santé, Appareil circulatoire pathologie
Mots-clés Pascal anglais : Cholesterol, Assay, Age criterion, Recommendation, Goal programming, Predictive factor, Coronary heart disease, Surveillance, Complication, Human, Young adult, Metabolic diseases, Dyslipemia, Hyperlipoproteinemia, Health education, Health economy, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0234062
Code Inist : 002B22A. Création : 11/06/1997.